How Adhesion/Growth-regulatory Galectins-1 and-3 Attain Cell Specificity: Case Study Defining Their Target on Neuroblastoma Cells (SK-N-MC) and Marked Affinity Regulation by Affecting Microdomain Organization of the Membrane
How Adhesion/Growth-regulatory Galectins-1 and-3 Attain Cell Specificity: Case Study Defining Their Target on Neuroblastoma Cells (SK-N-MC) and Marked Affinity Regulation by Affecting Microdomain Organization of the Membrane
复制标题
DOI:
10.1002/iub.358
复制
发表时间:
2010-08-01
期刊:
影响因子:
4.6
通讯作者:
Gabius, Hans-Joachim
中科院分区:
文献类型:
--
作者:
Kopitz, Juergen;Bergmann, Marion;Gabius, Hans-Joachim
Galectins are potent effectors with conspicuous cell-type-specific activity profile. Its occurrence poses the question on the nature of the underlying biochemical determinants, in human SK-N-MC neuroblastoma cells involved in negative growth regulation. Since increase of surface presentation of ganglioside GM1 and homodimeric galectin-1 precedes growth inhibition, a direct interaction is suggested. We thus examined cell binding depending on glucosylceramide synthesis. It was drastically reduced by N-butyldeoxynojirimycin and threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol, adding decisive evidence for the assumed galectin/ganglioside binding. Glycoproteins do not compensate ganglioside depletion which was verified by measuring lipid-bound sialic acid. Binding affinity is significantly lowered by disrupting microdomain integrity, also effective for the competitive inhibitor galectin-3. This was caused by cell treatment with either 2-hydroxypropyl-beta-cyclodextrin or filipin III. In this cell system, target specificity and topology of ligand presentation act together to enable high-affinity binding. (C) 2010 IUBMB IUBMB Life, 62(8): 624-628, 2010